FDA Restricts Patient Pool for Bluebird’s Skysona Amid Safety Concerns
Skysona can now only be used in patients with cerebral adrenoleukodystrophy who have no available treatment alternatives or stem cell donors.
FDA Restricts Patient Pool for Bluebird’s Skysona Amid Safety Concerns Read More »
